武聚山医生个人简介
主任医师，医学博士。北京医学会器官移植学分会委员，北京医学会外科学分会肝脏外科学组委员，中国医疗保健国际交流促进会肝脏肿瘤分会青委员。长期从事肝脏肿瘤及肝硬化门脉高压临床工作，在终末期肝病和肝癌肝移植方面有丰富临床经验。承担首都卫生发展科研专项基金1项，首都医科大学基础与临床科研基金课题1项。长期从事肝脏肿瘤及肝硬化门脉高压临床工作，在终末期肝病和肝癌肝移植方面有丰富临床经验。
代表性研究：
[1] Jiliang Feng, Junmei Chen, Ruidong Zhu, Lu Yu, Yan Zhang, Dezhao Feng, Heli Kong, Chenzhao Song, Hui Xia, Jushan Wu, Dawei Zhao;Prediction of early recurrence of hepatocellular carcinoma within the Milan criteria after radical resection. Oncotarget; 2017 Sep 8; 8(38): 63299–63310.[2] Qing-Fen Zheng, Jing-Yun Zhang, Ju-Shan Wu, Ying Zhang, Mei Liu, Li Bai, Jin-Yan Zhang, Jing Zhao, Yu Chen, Zhong-Ping Duan, Su-Jun Zheng;, Upregulation of miRNA-130a Represents Good Prognosis in Patients With HBV-Related Acute-on-Chronic Liver Failure: A Prospective Study. Medicine (Baltimore); 2016 Feb; 95(6): e2639.[3] Degang Kong, Xiuli Chen, Shichun Lu, Qingliang Guo, Wei Lai, Jushan Wu, Dongdong Lin, Daobing Zeng, Binwei Duan, Tao Jiang, Jilei Cao; Short-term effects of splenectomy on serum fibrosis indexes in liver cirrhosis patients. Int J Clin Exp Pathol; 2015 Nov; 8(11): 15260–15264.[4] Wei Lai, Shi-Chun Lu, Guan-Yin Li, Chuan-Yun Li, Ju-Shan Wu, Qing-Liang Guo, Meng-Long Wang, Ning Li,;Anticoagulation therapy prevents portal-splenic vein thrombosis after splenectomy with gastroesophageal devascularization. World J Gastroenterol; 2012 Jul 14; 18(26): 3443–3450
[5] Jiliang Feng, Jushan Wu, Ruidong Zhu, Dezhao Feng, Lu Yu, Yan Zhang, Dayu Bu, Chenlei Li, Yuyan Zhou, Lianghao Si, Yuhan Liu, Ziwei Liang, Jianing Xu, Tianjun Wu; Simple Risk Score for Prediction of Early Recurrence of Hepatocellular Carcinoma within the Milan Criteria after Orthotopic Liver Transplantation. Sci Rep; 2017 Mar; 7: 44036.[6]武聚山,段斌炜,李娟,金爱华,朱跃科,于红卫,孟庆华.Fibroscan检测对慢性HBV感染者肝纤维化临床分期的预测价值[J].中华传染病病杂志,2017,(8):498-500.[7]武聚山,李磊,宋艳明,封莉,李冰.肝硬化患者经内镜逆行胰胆管造影治疗的安全性分析[J].临床肝胆病杂志,2014,(12):1267-1271.[8]武聚山,卢实春,王孟龙,李宁,夏仁品,郭庆良,赖威,张毅,杨光,刘源.肝移植治疗原发性肝癌103例疗效观察[J].中华肝胆外科杂志,2009,15(10):748-750.
